Skip to content
-
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(PubMed)
-
Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain (PubMed)
-
Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine (PubMed)
-
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial (PubMed)
-
Cannabinoids for neuropathic pain (PubMed)
-
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (PubMed)
-
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial (PubMed)
-
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain (PubMed)
-
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation (PubMed)
-
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (PubMed)
-
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved (PubMed)
-
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (PubMed)
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors(PubMed)
-
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes (PubMed)
-
Cannabinoids in the management of difficult to treat pain (PubMed)
-
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (PubMed)
-
Marijuana extract helps prevent chemo pain (UPI)
-
Pot users less likely to take painkillers (American News Report)
-
Amygdala activity contributes to the dissociative effect of cannabis on pain perception (International Association for the Study of Pain)
-
Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review (British Journal of Clinical Pharmacology)
-
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (British Journal of Pharmacology)
-
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (PLOS)
-
Cannabinoid–Opioid Interaction in Chronic Pain (Clinical pharmacology & Therapeutics)
-
Cannabinoid receptors and pain (WIREs Membr Transp Signal)
-
Cannabinoids for Neuropathic Pain (Neuropathic Pain)
-
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials (British Journal of Clinical Pharmacology)
-
Cannabinoids in the management of difficult to treat pain (Therapeutics and Clinical Risk Management)
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting 3 glycine receptors (The Journal of Experimental Medicine)
-
Clinical Implications for Cannabinoid Use in the Rheumatic Diseases (Arthritis & Rheumatism)
-
Role of Cannabinoids in Pain Management (GW Pharmaceuticals)
-
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes (Bentham Science)
-
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain (HHS Public Access)
-
The Endocannabinoid System, Cannabinoids, and Pain (Rambam Maimonides Medical Journal)
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (National Institute on Drug Abuse)
